News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,314 Results
Type
Article (8018)
Company Profile (140)
Press Release (477155)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166740)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8573)
News (238192)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33154)
ALS (105)
Alzheimer's disease (983)
Antibody-drug conjugate (ADC) (273)
Approvals (10393)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (209)
Automation (28)
Bankruptcy (263)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (113)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (515)
Cancer (3694)
Cardiovascular disease (222)
Career advice (246)
Career pathing (1)
CAR-T (176)
CDMO (8)
Celiac Disease (1)
Cell therapy (481)
Cervical cancer (34)
Clinical research (47935)
Collaboration (1255)
Commercialization (3)
Compensation (1496)
Complete response letters (34)
COVID-19 (758)
CRISPR (64)
C-suite (766)
Cystic fibrosis (85)
Data (5738)
Denatured (4)
Depression (102)
Dermatology (64)
Diabetes (345)
Diagnostics (4196)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (157)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73735)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87912)
Executive appointments (706)
FDA (12431)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (929)
Gene editing (126)
Generative AI (9)
Gene therapy (327)
GLP-1 (291)
Government (946)
Grass and pollen (2)
Guidances (281)
Healthcare (9357)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (98)
Immuno-oncology (60)
Indications (158)
Infectious disease (946)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1969)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (13)
Liver cancer (45)
Longevity (18)
Lung cancer (517)
Lymphoma (255)
Machine learning (27)
Management (3)
Manufacturing (542)
Marketing (8)
MASH (118)
Medical device (8667)
Medtech (8815)
Mergers & acquisitions (14395)
Metabolic disorders (710)
mRNA (59)
Multiple sclerosis (104)
NASH (4)
Neurodegenerative disease (222)
Neuropsychiatric disorders (40)
Neuroscience (1840)
NextGen: Class of 2026 (3151)
Non-profit (842)
Obesity (225)
Opinion (10)
Ovarian cancer (160)
Pain (173)
Pancreatic cancer (202)
Parkinson's disease (202)
Partnered (12)
Patents (486)
Patient recruitment (515)
Peanut (31)
People (41276)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15481)
Phase 2 (21402)
Phase 3 (14434)
Pipeline (7490)
Policy (18)
Postmarket research (1570)
Preclinical (6544)
Press Release (34)
Prostate cancer (192)
Psychedelics (7)
Radiopharmaceuticals (191)
Rare diseases (579)
Real estate (3020)
Recruiting (6)
Regulatory (14877)
Reports (22)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (101)
Series A (157)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (331)
Venture capital (17)
Weight loss (73)
Women's health (83)
Date
Today (98)
Last 7 days (431)
Last 30 days (1629)
Last 365 days (19037)
2026 (12946)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34592)
2021 (37177)
2020 (33470)
2019 (23256)
2018 (17471)
2017 (18765)
2016 (17921)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20333)
Location
Africa (229)
Alabama (74)
Alaska (2)
Arizona (306)
Arkansas (11)
Asia (17926)
Australia (2104)
California (12163)
Canada (3188)
China (533)
Colorado (490)
Connecticut (419)
Delaware (208)
Europe (24659)
Florida (1819)
Georgia (386)
Hawaii (3)
Idaho (46)
Illinois (710)
India (52)
Indiana (317)
Iowa (15)
Japan (414)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1214)
Massachusetts (7971)
Michigan (309)
Minnesota (567)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (118)
New Hampshire (60)
New Jersey (2655)
New Mexico (12)
New York (2849)
North Carolina (1299)
North Dakota (4)
Northern California (6114)
Ohio (287)
Oklahoma (14)
Oregon (16)
Pennsylvania (2278)
Puerto Rico (20)
Rhode Island (30)
South America (407)
South Carolina (77)
South Dakota (1)
Southern California (5050)
Tennessee (122)
Texas (1974)
United States (39432)
Utah (364)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (944)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,314 Results for "tracelink inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Genetown
TraceLink to Present at the 39th Annual J.P. Morgan Healthcare Conference
TraceLink Inc ., the leading digital platform company for the life sciences industry, today announced that, for the fifth consecutive year, Shabbir Dahod , president and CEO of TraceLink, will present at the 39 th Annual J.P. Morgan Healthcare Conference on Thursday, January 14 at 8:40 am EST via virtual webcast.
January 11, 2021
·
1 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
Press Releases
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
·
6 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Genetown
TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement
TraceLink Inc., the leading digital platform company for the life sciences supply chain, today announced that Henry Schein, the world’s largest provider of health care solutions to office-based dental and medical practitioners, has implemented TraceLink’s verification router service (VRS) solution.
September 30, 2020
·
3 min read
Policy
TraceLink Achieves ISO 9001:2015 Certification for Quality Management
TraceLink Inc., the leading digital platform company for the life science supply chain, announced it has earned ISO 9001:2015 certification, a globally recognized quality management standard.
June 1, 2020
·
2 min read
Press Releases
Biogen Completes Acquisition of RayThera Inc.
August 7, 2026
·
7 min read
Genetown
TraceLink Announces First Round of Grant Recipients for COVID-19 Relief Funding
TraceLink Inc., the leading digital platform company for the life sciences industry, announced the first round of grant recipients in response to the Company’s commitment to a total of $1 Million in charitable funding for COVID-19 relief efforts to eligible organizations around the world.
November 2, 2020
·
4 min read
Press Releases
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results
August 31, 2026
·
10 min read
1 of 48,532
Next
